Insight into the mechanism of three component condensation leading to aminomethylenebisphosphonates

被引:43
作者
Dabrowska, Ewa [1 ]
Burzynska, Agnieszka [1 ]
Mucha, Artur [1 ]
Matczak-Jon, Ewa [2 ]
Sawka-Dobrowolska, Wanda [3 ]
Berlicki, Lukasz [1 ]
Kafarski, Pawel [1 ]
机构
[1] Wroclaw Univ Technol, Fac Chem, Dept Bioorgan Chem, PL-50370 Wroclaw, Poland
[2] Wroclaw Univ Technol, Fac Chem, Dept Inorgan & Struct Chem, PL-50370 Wroclaw, Poland
[3] Univ Wroclaw, Dept Chem, PL-50383 Wroclaw, Poland
关键词
Aminomethylenebisphosphonates; Reaction mechanism; Organophosphorus chemistry; DELIVERY SYSTEM ODDS; SOLUTION BEHAVIOR; DRUG-DELIVERY; BREAST-CANCER; AMINOMETHANE-1,1-DIPHOSPHONIC ACIDS; MOLECULAR-ORGANIZATION; BISPHOSPHONIC PRODRUG; TRYPANOSOMA-BRUCEI; BONE-RESORPTION; HYDROGEN-BONDS;
D O I
10.1016/j.jorganchem.2009.07.025
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Three-component reaction of a primary amine, diethyl phosphite and triethyl orthoformate followed by acid hydrolysis of the adduct provides N-substituted aminomethylenebisphosphonic acids in good yields. Being extremely versatile, it is commonly utilized for preparation of compounds possessing potential antiosteoporotic, antibacterial, anticancer, antiparasitic or herbicidal activity. However, the mechanism of the reaction remains unknown. p-Nitroaniline has been found an interesting tool to shed light on this matter. Its use allowed to separate and identify four intermediates, both non-phosphorus and phosphorus containing, and subsequently suggest the mechanism of the whole process. The acquired knowledge was helpful in explanation the route and the final product structure obtained for more complex reaction proceeding with the use of 4-aminopyridine. Additional alkylation of the pyridine nitrogen atom, leading to unexpected N-(1-alkylpyridinium-4-amino)methylenebisphosphonic acids was unambiguously proved. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:3806 / 3813
页数:8
相关论文
共 67 条
[1]  
ABE T, 1990, J BONE MINER RES S2, V5, P86
[2]   Detection of Breast Cancer Microcalcifications Using a Dual-modality SPECT/NIR Fluorescent Probe [J].
Bhushan, Kumar R. ;
Misra, Preeti ;
Liu, Fangbing ;
Mathur, Sanjeev ;
Lenkinski, Robert E. ;
Frangioni, John V. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (52) :17648-+
[3]   Zoledronate inhibits proliferation and induces apoptosis of imatinib- resistant chronic myeloid leukaemia cells [J].
Chuah, C ;
Barnes, DJ ;
Kwok, M ;
Corbin, A ;
Deininger, MWN ;
Druker, BJ ;
Melo, JV .
LEUKEMIA, 2005, 19 (11) :1896-1904
[4]   Bisphosphonates in breast cancer [J].
Coleman, RE .
ANNALS OF ONCOLOGY, 2005, 16 (05) :687-695
[5]   The discovery of a novel site of action for herbicidal bisphosphonates [J].
Cromartie, TH ;
Fisher, KJ ;
Grossman, JN .
PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY, 1999, 63 (02) :114-126
[6]  
DERIDDER DJA, 1990, ACTA CRYSTALLOGR C, V46, P2889
[7]   THE DESIGN AND SYNTHESIS OF BONE-ACTIVE PHOSPHINIC ACID ANALOGS .1. THE PYRIDYLAMINOMETHANE PHOSPHONALKYLPHOSPHINATES [J].
EBETINO, FH ;
JAMIESON, LA .
PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS, 1990, 51 (1-4) :23-26
[8]   A 99mTc-labeled gemcitabine bisphosphonate drug conjugate as a probe to assess the potential for targeted chemotherapy of metastatic bone cancer [J].
El-Mabhouh, Amal A. ;
Angelov, Christo A. ;
Cavell, Ron ;
Mercer, John R. .
NUCLEAR MEDICINE AND BIOLOGY, 2006, 33 (06) :715-722
[9]   Chemotherapeutic bone-targeted bisphosphonate prodrugs with hydrolytic mode of activation [J].
Erez, Rotem ;
Ebner, Sharon ;
Attali, Bernard ;
Shabat, Doron .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (02) :816-820
[10]   Bisphosphonates: Mechanisms of action [J].
Fleisch, H .
ENDOCRINE REVIEWS, 1998, 19 (01) :80-100